Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition

Neuroscience

Volumn 166, Issue 1, 2010, Pages 178-184

  Beste, C ^a   Baune, B T ^b   Domschke, K ^c   Falkenstein, M ^d   Konrad, C ^c,e  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

basal ganglia; BDNF val66met; event related potentials (ERPs); Nogo N2; Nogo P3; response inhibition

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; PROTEIN NOGO; PROTEIN NOGO N2; PROTEIN NOGO P3; UNCLASSIFIED DRUG; VALINE;

ADULT; ALLELE; AMPLITUDE MODULATION; ARTICLE; COGNITION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; NORMAL HUMAN; PREMOTOR CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPONSE TIME; STIMULUS RESPONSE; TASK PERFORMANCE;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; DNA MUTATIONAL ANALYSIS; ELECTROENCEPHALOGRAPHY; EXECUTIVE FUNCTION; FEMALE; GENETIC TESTING; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; METHIONINE; MODELS, NEUROLOGICAL; MYELIN PROTEINS; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; PSYCHOMOTOR PERFORMANCE; VALINE; YOUNG ADULT;

EID: 74449087315     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.12.022     Document Type: Article

References (53)

1. Andressoo J.O., and Saarma M. Signalling mechanisms underlying development and maintenance of dopamine neurons. Curr Opin Neurobiol 18 (2008) 297-306
2. Band G.P., and van Boxtel G.J. Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychol (Amst) 101 (1999) 179-211
3. Beck A.T., Ward C., and Mendelson M. Beck depression inventory (BDI). Arch Gen Psychiatry 4 (1961) 561-571
4. Bédard P., and Sanes J.N. On a basal ganglia role in learning and rehearsing visual-motor associations. Neuroimage 47 (2009) 1701-1710
5. Beste C., Willemssen R., Saft C., and Falkenstein M. Response inhibition subprocesses and dopaminergic pathways-basal ganglia disease effects. Neuropsychologia (2009) in press
6. Beste C., Dziobek I., Hielscher H., Willemssen R., and Falkenstein M. Effects of stimulus-response compatibility on inhibitory processes in Parkinson's disease. Eur J Neurosci 29 (2009) 855-860
7. Beste C., Saft C., Andrich J., Gold R., and Falkenstein M. Response inhibition in Huntington's disease-a study using ERPs and sLORETA. Neuropsychologia 46 (2008) 1290-1297
8. Bokura H., Yamaguchi S., and Kobayashi S. Event-related potentials for response inhibition in Parkinson's disease. Neuropsychologia 43 (2005) 967-975
9. Bruin K.J., Wijers A.A., and van Staveren A.S. Response priming in a go/nogo task: do we have to explain the go/nogo N2 effects in terms of response activation instead of inhibition?. Clin Neurophysiol 112 (2001) 1660-1671
10. Cepeda C., Hurst R.S., Calvert C.R., Hernández-Echeagaray E., Nguyen O.K., Jocoy E., Christian E.J., Ariano M.A., and Levine M.S. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 23 (2003) 961-969
11. Chen Z.Y., Patel P.D., Sant G., Meng C.X., Teng K.K., Hempstead B.L., and Lee F.S. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24 (2004) 4401-4411
12. Chudasama Y., and Robbins T.W. Functions of fronto-striatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 73 (2006) 19-38
13. Cummings D.M., Milnerwood A.J., Dallérac G.M., Waights V., Brown J.Y., Vatsavayai S.C., Hirst M.C., and Murphy K.P.S.J. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Hum Mol Genet 15 (2006) 2856-2868
14. DeLong M.R., and Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 64 (2007) 20-24
15. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolchana B.S., Bertolino A., Zaitsev E., Gold B., Goldman B., Dean M., Lu B., and Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003) 257-269
16. Falkenstein M., Hoormann J., and Hohnsbein J. ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychol (Amst) 101 (1999) 267-291
17. Fallgatter A.J., Ehlis A.C., Seifert J., Strik W.K., Scheuerpflug P., Zillessen K.E., Herrmann M.J., and Warnke A. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clin Neurophysiol 115 (2004) 973-981
18. Fumagalli F., Racagni G., and Riva M.A. Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease. Pharmacogenomics J 6 (2006) 95-104
19. Gale J.T., Amirnovin R., Williams Z.M., Flaherty A.W., and Eskandar E.N. From symphony to cacophony: pathophysiology of the human basal ganglia in Parkinson's disease. Neurosci Biobehav Rev 32 (2008) 378-387
20. Gasic G.P., Smoller J.W., Perlis R.H., Sun M., Lee S., Kim B.W., Lee M.J., Holt D.J., Blood A.J., Makris N., Kennedy D.K., Hoge R.D., Calhoun J., Fava M., Gusella J.F., and Breiter H.C. BDNF, relative preference, and reward circuitry responses to emotional communication. Am J Med Genet B Neuropsychiatr Genet 150 (2009) 762-781
21. Gauthier L.R., Charrin B.C., Borrell-Pagès M., Dompierre J.P., Rangone H., Cordelières F.P., Demey J., MacDonald M.E., Leßmann V., Humbert S., and Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004) 127-138
22. Goldberg T.E., and Weinberger D.R. Genes and the parsing of cognitive processes. Trends Cogn Sci 8 (2004) 325-335
23. Goldberg T.E., Iudicello J., Russo C., Elvevåg B., Straub R., Egan M.F., and Weinberger D.R. BDNF Val66Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Biol Psychol 77 (2008) 20-24
24. Gratton G., Coles M.G., and Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55 (1983) 468-484
25. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., and Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411 (2001) 86-89
26. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., and Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 23 (2003) 6690-6694
27. Humphries M.D., Stewart R.D., and Gurney K.N. A physiological plausible model of action selection and oscillatory activity in the basal ganglia. J Neurosci 26 (2006) 12921-12942
28. Johnson M.A., Rajan V., Miller C.E., and Wightman R.M. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem 97 (2006) 737-746
29. Kleim J.A., Chan S., Pringle E., Schallert K., Procaccio V., Jimenez R., and Cramer S.C. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 9 (2006) 735-737
30. Kosslyn S.M., and Koenig O. Wet mind: the new cognitive neuroscience (1992), The Free Press, New York/Toronto
31. Li C.S.R., Yan P., Sinha R., and Lee T.W. Subcortical processes of motor response inhibition during a stop signal task. Neuroimage 41 (2008) 1352-1363
32. Lotfipour S., Ferguson E., Leonard G., Perron M., Pike B., Richer L., Segun J.R., Toro R., Veillette S., Pausova Z., and Paus T. Orbitofrontal cortex and drug use during adolescence: role of prenatal exposure to maternal smoking and BDNF genotype. Arch Gen Psychiatry 66 (2009) 1244-1252
33. McHughen SA, Rodriguez PF, Kleim JA, Kleim ED, Crespo LM, Procaccio V, Cramer SC (in press) BDNF Val66Met polymorphism influences motor system function in the human brain. Cereb Cortex [doi:10.1093/cercor/bhp189].
34. Nagatsu T., and Sawada M. Biochemistry of post-mortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm Suppl 72 (2007) 113-120
35. Narita M., Aoki K., Takagi M., Yajima Y., and Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119 (2003) 767-775
36. Nieuwenhuis S., Yeung N., van den Wildenberg W., and Ridderinkhof K.R. Electrophysiological correlates of anterior cingulate function in a go/no-go task: effects of response conflict and trial type frequency. Cogn Affect Behav Neurosci 3 (2003) 17-26
37. Obeso J.A., Rodríguez-Oroz M.C., Benitez-Temino B., Blesa F.J., Guridi J., Marin C., and Rodriguez M. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov Disord 23 (2008) S548-S559
38. Oeth P., Beaulieu M., Park C., Kosman D., del Mistro G., van den Boom D., and Jurinke C. iPLEX™ assay: increased plexing efficiency and flexibility for MassARRAY system through single base primer extension with mass-modified terminators (2007). http://www.agrf.org.au/docstore/snp/iPlex.pdf
39. Oo T.F., Marchionini D.M., Yarygina O., O'Leary P.D., Hughes R.A., Kholodilov N., and Burke R.E. Brain-derived neurotrophic factor regulates early postnatal development cell death of dopamine neurons of the substantia nigra in vivo. Mol Cell Neurosci 41 (2009) 440-447
40. Reiss S., Peterson R.A., Gursky D.M., and McNally R.J. Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24 (1986) 1-8
41. Roche R.A., Garavan H., Foxe J.J., and O'Mara S.M. Individual differences discriminate event-related potentials but not performance during response inhibition. Exp Brain Res 160 (2005) 60-70
42. Saylor A.J., Meredith G.E., Vercillo M.S., Zahm D.S., and McGinty J.F. BDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression. Exp Neurol 199 (2006) 362-372
43. Saylor A.J., and McGinty J.F. Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice. Genes Brain Behav 7 (2008) 906-914
44. Schmajuk M., Liotti M., Busse L., and Woldorff M.G. Electrophysiological activity underlying inhibitory control processes in normal adults. Neuropsychologia 44 (2006) 384-395
45. Shimizu E., Hashimoto K., and Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet 126 (2004) 122-123
46. Solis O., Limón D.I., Flores-Hernández J., and Flores G. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 61 (2007) 450-458
47. Stephens B., Mueller A.J., Shering A.F., Hood S.H., Taggart P., Arbuthnott G.W., Bell J.E., Kilford L., Kingsbury A.E., Daniel S.E., and Ingham C.A. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 132 (2005) 741-754
48. Tang T.S., Chen X., Liu J., and Bezprozvanny I. Dopaminergic signaling and striatal neurodegeneration in Huntington's disease. J Neurosci 27 (2007) 7899-7910
49. Taverna S., Ilijic E., and Surmeier D.J. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28 (2008) 5504-5512
50. Tettamanti G., Cattaneo A.G., Gornati R., de Eguileor M., Bernardini G., and Binelli G. Phylogenesis of brain-derived neurotrophic factor (BDNF) in vertebrates. Gene 450 (2010) 85-93
51. Yohrling G.J., Farrell L.A., Hollenberg A.N., and Cha J.H.J. Mutant huntingtin increases nuclear corepressor function and enhances ligand-dependent nuclear hormone receptor activation. Mol Cell Neurosci 23 (2003) 28-38
52. Zordan L., Sarlo M., and Stablum F. ERP components activated by the "GO!" and "WITHHOLD!" conflict in the random sustained attention to response task. Brain Cogn 66 (2008) 57-64
53. Zuccato C., Tartari M., Crotti A., Goffredo D., Valenza M., Conti L., Cataudella T., Leavitt B.R., Hayden M.R., Timmusk T., Rigamonti D., and Cattaneo E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35 (2003) 76-83